Literature DB >> 17913471

Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections.

U-Syn Ha1, Yong-Hyun Cho.   

Abstract

Antibiotic treatment is the most effective method for managing recurrent uncomplicated urinary tract infections (UTIs) in women. However, there is a limitation to long-term antibiotic use, therefore alternative approaches are required. Escherichia coli is the commonest cause of recurrent uncomplicated UTIs and accounts for more than 60% of recurrent cystitis. It has therefore been suggested that immunostimulation with a bacterial extract consisting of immunostimulating components derived from 18 E. coli strains may protect against UTIs. Many in vitro studies, animal experiments and clinical trials in patients with recurrent UTIs have been carried out to assess the effectiveness and safety of E. coli extract for prophylaxis against recurrent UTIs. In this paper, we review the scientific evidence showing the anti-inflammatory effect of E. coli extract as well as the clinical results of placebo-controlled, randomised, double-blind studies that demonstrated a positive effect for E. coli extract in patients with recurrent UTIs. Evidence from available studies suggests that E. coli extract can be beneficial and safe for preventing recurrent UTIs in women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913471     DOI: 10.1016/j.ijantimicag.2007.07.018

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  2 in total

1.  A prospective multi-center trial of Escherichia coli extract for the prophylactic treatment of patients with chronically recurrent cystitis.

Authors:  Kun Suk Kim; Ji-Yoon Kim; In Gab Jeong; Jae-Seung Paick; Hwancheol Son; Dae Jung Lim; Hong Bang Shim; Won Hee Park; Hee Chang Jung; Myung-Soo Choo
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

2.  Multiple renal abscesses leading to nephrectomy of the solitary kidney in a young female with type 1 diabetes and history of recurrent urinary tract infections.

Authors:  Zofia Wańkowicz; Anna Grzywacz; Marek Saracyn; Henryk Zieliński
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.